Paytm, Adani Enterprises, HUL, Sun Pharma, Lupin, Cummins, GAIL, Macrotech Developers stocks in focus | The Financial Express

Paytm, Adani Enterprises, HUL, Sun Pharma, Lupin, Cummins, GAIL, Macrotech Developers stocks in focus

Markets are seeing time-wise correction and weak global cues are delaying the recovery. Continue with stock-specific trading approach.

Paytm, Adani Enterprises, HUL, Sun Pharma, Lupin, Cummins, GAIL, Macrotech Developers stocks in focus
Paytm, Adani Enterprises, HUL, Sun Pharma, Lupin, Cummins, GAIL, Macrotech Developers stocks in focus today

Indian benchmark indices may open in green amid positive global cues., hinted SGX Nifty. Ahead of the week’s last trading session, Nifty futures were trading 0.35% higher at 18792 on the Singapore exchange. “Markets are seeing time-wise correction and weak global cues are delaying the recovery. We feel the consolidation may continue for some time however buoyancy in the banking pack coupled with buying in select index majors may result in a further rebound. Meanwhile, we recommend continuing with stock-specific trading approach and focusing on buying opportunities,” said Ajit Mishra, VP – Technical Research, Religare Broking. In the previous session, BSE Sensex gained 160 points to 62,571, while NSE Nifty 50 rose 49 points to 18,609.

Stocks in focus on 9 December, Friday

Paytm: One 97 Communications Limited, the parent entity of Paytm, will hold a board meeting on 13 December to consider a proposal for a share buyback, the fintech major disclosed to the exchanges. “The management believes that given the Company’s prevailing liquidity/ financial position, a buyback may be beneficial for our shareholders. The outcome of the board meeting will be disseminated to the stock exchanges after conclusion of the Board meeting on 13 December 2022, in accordance with the applicable provisions of the SEBI Listing Regulations,” the announcement said.

Also Read: Investors see political stability in BJP’s dominance in India, eye benefits in paring dependence on China: EIU

HUL: Hindustan Unilever Ltd (HUL) has forayed into health and wellbeing category through strategic investments in Zywie Ventures’ OZiva and Nutritionalab’s Wellbeing Nutrition. HUL will acquire a 51% stake in OZiva through a combination of primary infusion and secondary buy-outs for a cash consideration of `264 crore. Balance 49% will be acquired at the end of 36 months on pre-agreed valuation criteria, HUL said. In Wellbeing Nutrition, HUL will acquire a 19.8% stake through a combination of primary infusion and secondary buyouts for a cash consideration of Rs 70 crore.

Cummins India, GAIL: Power solutions company, Cummins announced on Thursday that it would provide technology to build one of India’s largest proton exchange membrane (PEM) electrolyser for GAIL at Vijaipur, in Madhya Pradesh in collaboration with EPC player Tecnimont, the Indian subsidiary of Maire Tecnimont Group. This project is expected to produce 4.3 tonne of green hydrogen per day. This was the largest green hydrogen plant in the country with a capacity of 10 MW.

Sun Pharma: The company on Thursday clarified further on US Food and Drug Administration (FDA) listing its Halol plant on import alert. In a regulatory filing, clarifying the effect on the revenue and the revision of future guidance of the company, Sun Pharma stated that US supplies from Halol contributed approximately 3% of consolidated revenues for the year ended March 31, 2022, including sales from exempted products. “We are not revising our revenue guidance for the current financial year,” it said. It also added that there will be no impact on the specialty revenues either.

Adani Enterprises: The company has acquired a 100% stake in Alluvial Mineral Resources, from Adani Infra (India). Alluvial Mineral Resources is engaged in the mining of minerals & ores activities and other allied activities.

Lupin: The pharma major has appointed Spiro Gavaris as President of the US generics business. He most recently served as President of the specialty generics business at Mallinckrodt Pharmaceuticals and the president of US injectables at Hikma.

Macrotech Developers: Realty firm Macrotech Developers’ promoters plan to raise about Rs 3,500 crore by selling shares to institutional investors, according to sources. In a regulatory filing, the company informed that the company has launched Qualified Institutional Placement (QIP) of the equity shares. The QIP consists of an offer-for-sale (OFS) of shares by promoter group entities — Sambhavnath Trust, Sambhavnath Infrabuild and Farms, Hightown Constructions, and Homecraft Developers and Farms, the filing said.

Also Read: Markets Wrap Up – 8 December: Stocks rise, rupee falls; Asia, Europe markets, Gold, Crude, Crypto updates

Max Financial Services: The company has completed the acquisition of balance 5.17% stake in Max Life Insurance Company, from Mitsui Sumitomo Insurance Company, Japan. After this transaction, its shareholding in Max Life stands increased to 87%.

Get live Share Market updates and latest India News and business news on Financial Express. Download Financial Express App for latest business news.

First published on: 09-12-2022 at 07:12:34 am
Photos
7 Photos
Nepal plane crash: Flight with 72 onboard crashes near Pokhara International Airport – Images
7 Photos
Business heads run at Mumbai Marathon, more than 50,000 people participate in event – See pictures here
9 Photos
Himachal snowfall: Tourist footfall increases in snow-clad Shimla, other regions of hill state – Pictures inside